MRCP Part 1 → Clinical sciences
Clinical sciences accounts for roughly 12.5% of the MRCP Part 1 blueprint. This bank has 555 items tagged to it.
Around 12.5% of the paper, per MRCP(UK) examination blueprints and regulations. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
Minutes after eating a takeaway containing peanuts, a 25-year-old man develops widespread urticaria, swelling of his lips and tongue, wheeze and stridor, and becomes hypotensive with a systolic of 80 mmHg. He is anxious and short of breath. What is the most likely diagnosis?
The point: Anaphylaxis is a severe, life-threatening, whole-body allergic reaction. Most often, it is a type I reaction driven by the antibody IgE: an allergen locks onto IgE sitting on mast cells and basophils (types of immune cell), which sets off a massive release of histamine and other chemical messengers. It comes on fast, usually within minutes of meeting a trigger such as food (nuts, shellfish), a drug (antibiotics, especially penicillins, and NSAIDs), an insect sting, or latex. The diagnosis is made clinically: a sudden start with rapidly worsening problems in the Airway, Breathing or Circulation (a harsh noise on breathing in, called stridor, and swelling; wheeze and low oxygen; or low blood pressure and collapse), usually together with skin and mucosal changes such as hives (urticaria) and swelling under the skin (angioedema), though skin changes can sometimes be absent. The single most important treatment is adrenaline given into the muscle of the outer thigh (0.5 mg of the 1 in 1000 strength in an adult), given straight away and repeated after 5 minutes if there is no improvement. Giving adrenaline late is the commonest avoidable reason people die from anaphylaxis. Alongside this, the patient is positioned appropriately (lying flat with the legs raised if their blood pressure is low, or sitting up if breathing is the main problem), given high-flow oxygen and fluids into a vein for low blood pressure, and the trigger is removed. Antihistamines and steroids are no longer used as the first treatment, and if given at all, they come after adrenaline. A blood test for mast-cell tryptase (a marker released by mast cells), taken during and after the reaction, supports the diagnosis after the event. Once the patient has recovered, they are watched for a second wave of symptoms (a biphasic reaction), given adrenaline auto-injector pens with training on how to use them, and referred to an allergy clinic to find the trigger. Anaphylaxis is a clear example of the type I hypersensitivity immunology that MRCP tests in clinical sciences.
Source: Resuscitation Council UK — emergency treatment of anaphylaxis guideline Resuscitation Council UK · tier 2, specialty society or college
Minutes after eating a takeaway containing peanuts, a 25-year-old man develops widespread urticaria, swelling of his lips and tongue, wheeze and stridor, and becomes hypotensive with a systolic of 80 mmHg. He is anxious and short of breath. What is the most appropriate investigation?
The point: Anaphylaxis is a severe, life-threatening, whole-body allergic reaction. Most often, it is a type I reaction driven by the antibody IgE: an allergen locks onto IgE sitting on mast cells and basophils (types of immune cell), which sets off a massive release of histamine and other chemical messengers. It comes on fast, usually within minutes of meeting a trigger such as food (nuts, shellfish), a drug (antibiotics, especially penicillins, and NSAIDs), an insect sting, or latex. The diagnosis is made clinically: a sudden start with rapidly worsening problems in the Airway, Breathing or Circulation (a harsh noise on breathing in, called stridor, and swelling; wheeze and low oxygen; or low blood pressure and collapse), usually together with skin and mucosal changes such as hives (urticaria) and swelling under the skin (angioedema), though skin changes can sometimes be absent. The single most important treatment is adrenaline given into the muscle of the outer thigh (0.5 mg of the 1 in 1000 strength in an adult), given straight away and repeated after 5 minutes if there is no improvement. Giving adrenaline late is the commonest avoidable reason people die from anaphylaxis. Alongside this, the patient is positioned appropriately (lying flat with the legs raised if their blood pressure is low, or sitting up if breathing is the main problem), given high-flow oxygen and fluids into a vein for low blood pressure, and the trigger is removed. Antihistamines and steroids are no longer used as the first treatment, and if given at all, they come after adrenaline. A blood test for mast-cell tryptase (a marker released by mast cells), taken during and after the reaction, supports the diagnosis after the event. Once the patient has recovered, they are watched for a second wave of symptoms (a biphasic reaction), given adrenaline auto-injector pens with training on how to use them, and referred to an allergy clinic to find the trigger. Anaphylaxis is a clear example of the type I hypersensitivity immunology that MRCP tests in clinical sciences.
Source: Resuscitation Council UK — emergency treatment of anaphylaxis guideline Resuscitation Council UK · tier 2, specialty society or college
Minutes after eating a takeaway containing peanuts, a 25-year-old man develops widespread urticaria, swelling of his lips and tongue, wheeze and stridor, and becomes hypotensive with a systolic of 80 mmHg. He is anxious and short of breath. What is the most appropriate management?
The point: Anaphylaxis is a severe, life-threatening, whole-body allergic reaction. Most often, it is a type I reaction driven by the antibody IgE: an allergen locks onto IgE sitting on mast cells and basophils (types of immune cell), which sets off a massive release of histamine and other chemical messengers. It comes on fast, usually within minutes of meeting a trigger such as food (nuts, shellfish), a drug (antibiotics, especially penicillins, and NSAIDs), an insect sting, or latex. The diagnosis is made clinically: a sudden start with rapidly worsening problems in the Airway, Breathing or Circulation (a harsh noise on breathing in, called stridor, and swelling; wheeze and low oxygen; or low blood pressure and collapse), usually together with skin and mucosal changes such as hives (urticaria) and swelling under the skin (angioedema), though skin changes can sometimes be absent. The single most important treatment is adrenaline given into the muscle of the outer thigh (0.5 mg of the 1 in 1000 strength in an adult), given straight away and repeated after 5 minutes if there is no improvement. Giving adrenaline late is the commonest avoidable reason people die from anaphylaxis. Alongside this, the patient is positioned appropriately (lying flat with the legs raised if their blood pressure is low, or sitting up if breathing is the main problem), given high-flow oxygen and fluids into a vein for low blood pressure, and the trigger is removed. Antihistamines and steroids are no longer used as the first treatment, and if given at all, they come after adrenaline. A blood test for mast-cell tryptase (a marker released by mast cells), taken during and after the reaction, supports the diagnosis after the event. Once the patient has recovered, they are watched for a second wave of symptoms (a biphasic reaction), given adrenaline auto-injector pens with training on how to use them, and referred to an allergy clinic to find the trigger. Anaphylaxis is a clear example of the type I hypersensitivity immunology that MRCP tests in clinical sciences.
Source: Resuscitation Council UK — emergency treatment of anaphylaxis guideline Resuscitation Council UK · tier 2, specialty society or college
Clinical pharmacology and therapeutics · Cardiology · Respiratory medicine · Gastroenterology and hepatology · Neurology · Endocrinology, diabetes and metabolic medicine · Renal medicine · Infectious diseases · Rheumatology · Haematology · Psychiatry · Dermatology · Geriatric medicine · Oncology · Medical ophthalmology · Palliative medicine and end of life care